The doctor was kind. She listened, she nodded, and she offered you a prescription for an antidepressant. And maybe you took it, because you were exhausted and frightened and you trusted that she knew what was happening. But something did not sit right. You did not feel depressed in the way you understood depression. This felt different. It felt physical in a way you could not explain, like something had changed in the wiring, not in your circumstances.

That instinct was worth listening to. Anxiety and depression in perimenopausal women are frequently misidentified as primary psychological conditions when they are in fact symptoms of a hormonal shift. Antidepressants are prescribed as a first response without any assessment of hormonal status, and women spend months or years on medications that partially help but do not address the underlying cause. The correct treatment, one that looks at the hormonal picture first, can look very different and can work faster and more completely.

This article explains why perimenopause produces symptoms that look like anxiety and depression, how to tell the difference, what the research says about hormonal treatment for these symptoms, and how to have a more informed conversation with your doctor about what is actually happening.

Why estrogen affects mood so directly

Estrogen is a neuroactive hormone. It does not just act on the reproductive system. It crosses the blood-brain barrier and has direct effects on the brain’s neurotransmitter systems, the chemical signaling pathways that regulate mood, motivation, anxiety, and cognitive function.

Estrogen supports the production and recycling of serotonin, the neurotransmitter most associated with mood regulation and the primary target of the SSRI antidepressants that are most commonly prescribed. When estrogen is stable and adequate, serotonin function tends to be stable too. When estrogen fluctuates or declines, serotonin activity fluctuates with it. This is a direct, measurable neurochemical effect.

Estrogen also supports dopamine, which regulates motivation, reward, and the ability to feel pleasure. It modulates GABA, the brain’s calming neurotransmitter. It affects the activity of the HPA axis, which governs the stress response and cortisol production. In short, estrogen is deeply involved in the neurological systems that, when disrupted, produce what looks like clinical anxiety and depression.

This is not a metaphor or a loose correlation. It is a well-documented mechanism, and it is why mood symptoms are so common during perimenopause and why they often respond differently to treatment than mood disorders that develop independently of hormonal change.

How perimenopausal mood symptoms differ from clinical depression

The overlap between perimenopausal mood symptoms and clinical depression is real, which is part of why misdiagnosis happens. Both can include low mood, loss of motivation, difficulty concentrating, disrupted sleep, increased anxiety, irritability, and social withdrawal.

The differences tend to be in the pattern and the context. Perimenopausal mood symptoms often fluctuate in correlation with the menstrual cycle, even an irregular one. Women frequently notice that their lowest days cluster around certain points in the month. The symptoms often have a physical quality, a sense of something biochemical happening, rather than a felt sense of persistent hopelessness or worthlessness. They often arrived simultaneously with other physical perimenopause symptoms: cycle changes, sleep disruption, hot flashes, or physical fatigue.

The onset is also often sudden and recent, rather than consistent with a lifetime history of anxiety or depression. A woman who has never had a significant mood disorder, who has been broadly mentally healthy for four decades, who then develops significant anxiety or low mood in her early 40s alongside other physical changes, is presenting with a different clinical picture from someone with a long-standing depressive condition.

Research from the Harvard Study of Moods and Cycles found that women who had no prior history of depression were two to four times more likely to develop depressive symptoms during perimenopause than during their premenopausal years. The transition itself was a risk factor, not background vulnerability.

The problem with antidepressants as a first response

Antidepressants are not the wrong treatment for everyone with perimenopausal mood symptoms. SSRIs and SNRIs do have evidence for reducing hot flash frequency as well as mood symptoms in perimenopausal women, and for some women they are a useful tool.

The problem is when they are offered as a first and only response to mood symptoms in a perimenopausal woman, without any assessment of hormonal status, without any discussion of the hormonal context, and without informing the woman that her symptoms may be hormonally driven and that hormonal treatment is an option.

Women who receive antidepressants without hormonal assessment may find partial improvement. The serotonin support provided by SSRIs does help when serotonin is deficient. But the other neurochemical effects of estrogen fluctuation, the GABA dysregulation, the cortisol effects, the dopamine impact, are not addressed. The hot flashes, night sweats, brain fog, joint pain, and other physical symptoms continue. The woman remains in the dark about why she is struggling.

For women whose anxiety or depression is primarily hormonally driven, the most effective treatment is often estrogen therapy, sometimes combined with progesterone, rather than antidepressants alone. Several studies, including work from Johns Hopkins and the Penn Center for Women’s Behavioral Wellness, have found that transdermal estradiol can be effective for perimenopausal depression, sometimes dramatically so, particularly for women with vasomotor symptoms.

How to have this conversation with your doctor

If you have been prescribed antidepressants for anxiety or depression in your 40s and you have not had a conversation about whether your symptoms might be hormonally driven, raise it directly.

Come prepared with a clear symptom history: when the mood symptoms started, whether they fluctuate with your cycle, what other physical symptoms you have noticed, and how long you have been experiencing cycle changes. Be specific about the pattern.

Ask your doctor explicitly: “Could my mood symptoms be related to perimenopause? Has my hormonal status been assessed? What would a hormonal approach to my symptoms look like?”

If the response is dismissal of the hormonal question, or a reiteration that antidepressants are the appropriate treatment without any discussion of alternatives, seeking a second opinion from a provider who specializes in menopause medicine is a reasonable next step. You are entitled to a complete assessment.

Your next step is to write down your symptoms in timeline form, noting when physical changes started alongside mood changes. That pattern on paper often tells a story that is harder to dismiss than a description in a ten-minute appointment.

Medical disclaimer: This article is for educational purposes only and is not medical advice. It is not a diagnosis, treatment plan, or substitute for care from a qualified healthcare professional. If you have concerning symptoms, seek medical care promptly.